Close

Intersect ENT's (XENT) Study of RESOLVE In-Office Steroid Releasing Implant Met Both Co-Primary Efficacy Endpoints

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. META
4. TXN
5. SPOT
6. BA
7. V
8. IBM
9. KMB
10. HCP


Go back to Intersect ENT's (XENT) Study of RESOLVE In-Office Steroid Releasing Implant Met Both Co-Primary Efficacy Endpoints
(NASDAQ: XENT) Delayed: 28.24 --0 (-0%)
Previous Close $28.24    52 Week High $23.00 
Open $28.24    52 Week Low $7.65 
Day High $28.24    P/E N/A 
Day Low $28.24    EPS $0.00 
Volume 200